NCT05701540View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn

PHASE4UnknownINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Tegoprazan

Tegoprazan 50mg tablet

DRUG

Esomeprazole

"Esomeprazole 20mg tablet~1. For patients with ERD: two Esomeprazole 20mg tablets~2. For patients with NERD: one Esomeprazole 20mg tablet"

Trial Locations (1)

03722

RECRUITING

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT05701540 - A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn | Biotech Hunter | Biotech Hunter